P982: EFFICACY AND SAFETY OF 40 MG VS 60 MG OF ONCE WEEKLY SELINEXOR IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM)

• Darrell White,
• Muhamed Baljevic,
• Gary Schiller,
• Suzanne Lentzsch,
• Evgeni Chubar,
• Noa Lavi,
• Dane Van Domelen,
• Ohad Bentur,
• Sumit Madan

Affiliations

Darrell White

1 Dalhousie University, Halifax, Canada

Muhamed Baljevic

2 Vanderbilt University, Nashville, United States

Gary Schiller

3 David Geffen School of Medicine at UCLA, Los Angeles, United States

Suzanne Lentzsch

4 Columbia University, New York, United States

Evgeni Chubar

5 Emek Medical Center, Afula, Israel

Noa Lavi

6 Rambam Health Care Campus, Haifa, Israel

Dane Van Domelen

7 Karyopharm Therapeutics, Newton, United States

Ohad Bentur

7 Karyopharm Therapeutics, Newton, United States

Sumit Madan

8 Banner MD Anderson Cancer Center at Banner - University Medical Center Phoenix, Phoenix, United States